In re ACTOS Antitrust Litigation
Case Number:
1:13-cv-09244
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Anapol Weiss
- Coffman Law Firm
- Cohen Milstein
- Cohen Placitella
- DiCello Levitt
- Edelson PC
- Elliott Kwok
- Faruqi & Faruqi
- Friedman Law Group Ltd.
- Girard Sharp
- Glancy Prongay
- Goldstein & McClintock
- Hach Rose Schirripa
- Hagens Berman
- Hilliard & Shadowen
- Kehoe Law
- Kirkland & Ellis
- Labaton Keller
- Latham & Watkins
- Lieff Cabraser
- Milberg Coleman
- Miller Shah LLP
- Morgan Lewis
- Motley Rice
- Munger Tolles
- Nussbaum Law Group
- Pomerantz LLP
- Radice Law Firm
- Reinhardt Wendorf
- Robbins Geller
- Robbins LLP
- Safirstein Law
- Simmons Hanly
- Skadden Arps
- Sperling Kenny
- Spiro Harrison
- Wexler Boley
- Wilson Sonsini
- Winston & Strawn
Companies
- Allergan PLC
- Crosby Tugs LLC
- Fraternal Order of Police
- Ranbaxy
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
- Viatris Inc.
Sectors & Industries:
-
May 20, 2015
FTC's Abbvie Loss Doesn't Apply To Actos Case, Court Told
The plaintiffs accusing Takeda Pharmaceutical Co. and other drugmakers of participating in a pay-for-delay scheme for the Actos diabetes drug argued Tuesday in New York federal court that a recent high-profile ruling against the Federal Trade Commission in a similar filing should not have any bearing on the case.
-
May 13, 2015
Takeda Says FTC's AbbVie Loss Backs Actos Dismissal Bid
Takeda Pharmaceutical Co. Ltd. and several generic-drug makers accused of delaying cheaper versions of diabetes treatment Actos on Tuesday said the recent dismissal of a chunk of one of the Federal Trade Commission's own pay-for-delay cases has doomed the Actos antitrust litigation.
- ← Previous
- 1
- 2
- Next →